Understand the source comparison
Amylin Versus GLP-1 Versus Dual Mechanisms
Because cagrilintide is frequently discussed alongside GLP-1 receptor agonists such as semaglutide, and because the combination (CagriSema) is a major focus of the development program, it helps to contrast the mechanisms. Amylin analogues and GLP-1 agonists bo
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Because cagrilintide is frequently discussed alongside GLP-1 receptor agonists such as semaglutide, and because the combination (CagriSema) is a major focus of the development program, it helps to contrast the mechanisms. Amylin analogues and GLP-1 agonists both reduce appetite and slow gastric emptying, but they act through different receptors and partly different brain circuits, which is the rationale for combining them. The table below organizes the comparison; entries describe class-level mechanisms rather than head-to-head clinical superiority for any specific endpoint.
- Primary receptor target
- AMY1/AMY3 (CTR + RAMP1/RAMP3)
- GLP-1 receptor
- Both receptor systems engaged
- Appetite/satiety effect
- Yes, via hindbrain circuits
- Yes, via GLP-1 circuits
- Complementary appetite signaling
- Gastric emptying
- Slows (amylin-class effect)
- Slows
- Postprandial glucagon
- Suppresses (amylin-class effect)
- Glucose-dependent suppression
- Combined glucagon effects
- Direct incretin/insulin-secretion effect
- Not a primary mechanism
- Yes, glucose-dependent insulin secretion
- Present via GLP-1 component
- The takeaway from this comparison is that amylin and GLP-1 pathways are complementary rather than redundant, which is precisely why the combination has been pursued. For prediabetes specifically, however, the same caveat applies to all three columns: mechanistic complementarity is a reason to study these agents for glucose-risk endpoints, not evidence that any of them prevents diabetes in a prediabetes population. Readers exploring the combination can review the related cagrilintide–semaglutide blend reference and the semaglutide reference for context on each component.